v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Mar. 30, 2025
Mar. 31, 2024
Operating activities:    
Net income (loss) $ (148,086) $ 14,762
Reconciliation of net income (loss) to net cash provided by operating activities, net of acquisitions:    
Goodwill and intangible impairment 138,220 19,762
Depreciation and amortization 40,287 40,578
Amortization of deferred financing costs 561 541
Deferred income taxes (10,419) (8,535)
Bad debt expense 444 418
Stock-based compensation 9,106 7,641
Other non-cash items (161) (122)
Changes in operating items:    
Trade receivables (11,133) (6,778)
Inventories 17,569 31,674
Prepaid and other 1,669 4,761
Accounts payable and accrued expenses (38,946) (6,077)
Other assets and liabilities 1,595 1,426
Net cash provided by operating activities 706 100,051
Investing activities:    
Acquisitions, net of cash acquired (3,000) 0
Capital expenditures (32,431) (26,482)
Net cash used in investing activities (35,431) (26,482)
Financing activities:    
Acquisition of treasury stock (9,913) (9,178)
Proceeds from exercise of employee stock options 281 258
Proceeds from bank borrowings 110,000 82,000
Repayment of bank borrowings (140,000) (89,500)
Debt issuance cost (396) 0
Net cash used in financing activities (40,028) (16,420)
Net change in cash and cash equivalents (74,753) 57,149
Cash and cash equivalents:    
Beginning of period 159,437 126,807
End of period $ 84,684 $ 183,956